UTHR MEXC RealStocks
Own real UTHR shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1

Last updated: 2026-11-12 11:41:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
United Therapeutics Corp. (UTHR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $580.50, with a market capitalization of $25.07B and a P/E ratio of 20.61. Over the past 52 weeks, its price has ranged from $452.44 to $614.23. This page covers its latest market performance, valuation, price trends and company information.
$25.07B | |
$597.49 | |
$597.49 | |
$580.50 | |
$595.66 | |
6.00 | |
709.58K | |
20.61 | |
$614.23 | |
$452.44 | |
-- | |
-- |
United Therapeutics Corp. (UTHR) is trading at $580.50 in pre-market trading as of 2026-11-12 09:02:00, down 2.54% ($15.16) from the previous close of $595.66
Pre-market trading shows how investors are pricing UTHR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, United Therapeutics Corp. (UTHR) moved from $601.32 to $580.50, representing a decline of 3.46% ($20.82).
The stock traded between $556.63 and $614.23 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 578.44 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 79.2%
UTHR is currently trading at $580.50, placing it 79.2% of the way from its 52-week low of $452.44 to its 52-week high of $614.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 1,400 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for United Therapeutics Corp.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of United Therapeutics Corp. (UTHR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to UTHR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between UTHR shares and USD.
UTHR Shares to USD
1.00 UTHR shares = 580.502 USD
Calculations are estimates based on the latest available price and are for reference only.